Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / CL A
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
17,300
-
Shares change
-
-31,376,092
-
Total reported value, excl. options
-
$2,981,708
-
Value change
-
-$3,198,726,480
-
Number of sells
-
-204
-
Price
-
$172.36
Significant Holders of REATA PHARMACEUTICALS INC - CL A (RETA) as of Q3 2023
227 filings reported holding RETA - REATA PHARMACEUTICALS INC - CL A as of Q3 2023.
REATA PHARMACEUTICALS INC - CL A (RETA) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17,300 shares
.
Largest 10 shareholders include DekaBank Deutsche Girozentrale (17,000 shares), IFP Advisors, Inc (300 shares), Solidarity Wealth, LLC (0 shares), Bank of New York Mellon Corp (0 shares), Lindbrook Capital, LLC (0 shares), EMERALD ADVISERS, LLC (0 shares), EMERALD MUTUAL FUND ADVISERS TRUST (0 shares), STRS OHIO (0 shares), TRANSCEND CAPITAL ADVISORS, LLC (0 shares), and JFS WEALTH ADVISORS, LLC (0 shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.